Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. DXCM
DXCM logo

DXCM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DXCM News

DEXCOM STOCK RISES 0.4% FOLLOWING EVERCORE ISI UPGRADE TO OUTPERFORM FROM IN LINE

6d agomoomoo

MIG Capital Reduces Stake in Sotera Health by $37 Million

Mar 15 2026Yahoo Finance

Adobe CEO Resignation Triggers Stock Decline

Mar 13 2026CNBC

Dexcom G7 Enhances Diabetes Management and Health Outcomes

Mar 11 2026Newsfilter

Dexcom CGM Enhances Long-Term Health for Diabetes Patients

Mar 11 2026Yahoo Finance

Intuitive Surgical and DexCom: Future Prospects Analysis

Mar 10 2026Fool

Intuitive Surgical and DexCom's Growth Prospects Amid Challenges

Mar 10 2026NASDAQ.COM

Investigation into DexCom Officers' Fiduciary Duties

Feb 26 2026PRnewswire

DexCom Positioned to Benefit from GLP-1 Drug Boom

Feb 25 2026Fool

DexCom Benefits from the Rise of GLP-1 Medications

Feb 25 2026NASDAQ.COM

DexCom to Present Company Update at 47th Annual Raymond James Conference

Feb 25 2026Newsfilter

U.S. Stocks Close Higher as Software Stocks Recover

Feb 14 2026NASDAQ.COM

Wall Street Rebounds as Inflation Data Surprises

Feb 13 2026Benzinga

US Stocks Edge Up, Led by Chipmakers' Gains

Feb 13 2026NASDAQ.COM

Significant Stock Movements for Moderna and Others

Feb 13 2026CNBC

Coinbase Reports Q4 Revenue Decline of 5%

Feb 13 2026Benzinga